Combination of mglur antagonists for the treatment of addictive disorders
CA 2498022 C · Owner: Semenova, Svetlana · Inventors: Paterson, Neil; Kenny, Paul; Markou, Athina
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods are provided for treating disorders associated with mGlu receptors by simultaneously inhibiting at least two mGIuRs belonging to at least two different groups. In one embodiment, there are provided methods for treating a disorder associated with mGlu receptors 2 3, and 5, including administering , to a subject in need thereof an effective amount of at least one antagonist which modulates mGIuR2, mGIuR3, and mGIuRS. The disorders treated by the method include, for example, nicotine addiction cocaine addiction, and , depression.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 10, 2003 and granted October 23, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 10, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 10, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.